What are the possible causes of low alkaline phosphatase in a 16‑year‑old?

Causes of Low Alkaline Phosphatase in a 16-Year-Old

In a 16-year-old with low ALP, the most important distinction is between transient hypophosphatasemia (which accounts for >95% of cases) versus persistent low ALP, where hypophosphatasia (HPP) is the primary genetic cause to rule out, though acquired conditions like malnutrition, hypothyroidism, and medication effects are more common overall.

Algorithmic Approach to Low ALP

Step 1: Confirm Persistence

• Repeat ALP measurement using age- and sex-specific reference ranges 1, 2
• If ALP normalizes on repeat testing → transient hypophosphatasemia (95.4% of cases) 3
• If persistently low (≥2 measurements) → proceed to Step 2

Step 2: Identify Common Acquired Causes

The most frequent causes of persistent low ALP in adolescents include 4, 3:

Nutritional/Metabolic:

• Malnutrition or calorie depletion (most common in persistent cases) 3
• Anemia (most common associated diagnosis overall) 2
• Vitamin/mineral deficiencies 5

Endocrine:

• Hypothyroidism 4

Medications:

• Corticosteroid administration 4
• Antiresorptive therapy 5
• Chemotherapy agents 6

Other:

• Chronic diseases 2
• Cardiopulmonary bypass 6

Step 3: Screen for Hypophosphatasia (HPP)

HPP should be strongly considered when persistent low ALP is accompanied by:

Major criteria 7:

• Pathogenic/likely pathogenic ALPL gene variant
• Elevated ALP substrates: pyridoxal-5'-phosphate (PLP) and/or urinary phosphoethanolamine (PEA) 1, 8
• Early loss of primary teeth

Minor criteria 7:

• Short stature (more common in HPP patients; weak positive correlation between ALP z-scores and height) 4
• Muscle weakness or hypotonia 4, 8
• Delayed motor development 4
• Bone pain or pseudofractures 8
• Dental abscesses 8
• Decreased bone mineral density 7

Diagnosis requires: 2 major criteria OR 1 major + 2 minor criteria 7

Diagnostic Testing Sequence

For patients with persistent low ALP:

1. Measure ALP substrates 1, 2:

   • Plasma pyridoxal-5'-phosphate (PLP)
   • Urinary phosphoethanolamine (PEA)
   • Note: Negative correlation exists between total ALP and PLP (Rho = -0.55) 3

2. If PLP and/or PEA elevated → Proceed to ALPL gene sequencing 1, 2

   • HPP confirmed in 13.5% of children with persistent low ALP and elevated substrates 2
   • In one large pediatric cohort, HPP represented 0.71% of all children with low ALP 3

3. Radiographic evaluation if HPP suspected: look for rickets, pseudofractures, or skeletal abnormalities 8

Critical Pitfalls to Avoid

• Don't dismiss mildly low ALP: Even asymptomatic patients with persistently low ALP may have HPP and can develop symptoms later 1
• Age-specific reference ranges are essential: ALP varies significantly with age in adolescents; failure to use appropriate norms leads to missed or false diagnoses 9, 1
• Normal gene sequencing doesn't exclude HPP: A substantial proportion of patients with clinical HPP have normal ALPL exon sequencing, possibly due to regulatory region mutations or epigenetic changes 5
• High phenotypic variability: Even patients with identical ALPL variants can present very differently 3

Frequency Context

In the largest pediatric screening studies 2, 3:

• Hypophosphatasemia detected in 0.9% of all samples
• Persistent hypophosphatasemia: 0.06% (1/1552 children)
• Clinically significant HPP: rare, but represents 4.1-15.5% of those with persistent low ALP depending on screening criteria

The key clinical decision point is distinguishing transient from persistent low ALP through repeat measurement, then systematically evaluating for acquired causes before pursuing the more extensive HPP workup with substrate measurement and genetic testing.